Genetic Testing

Genetic factors contribute to some 30 percent of breast cancer cases in South Africa, necessitating investment in genomic research in African contexts

This new publication sets the standard, enabling more personalized and targeted breast cancer prevention and detection

PROSTOX ultra is the first and only molecular diagnostic test to use biology and genetics to predict radiation toxicity

Large-scale functional studies are emerging that offer promise to improve variant interpretation

The first phase of the Stratified Medicine Paediatrics program shows that ctDNA blood tests can provide crucial insights for targeting treatments and tracking childhood cancer progression

Ultralow variant detection enables a stronger characterization of a sample’s current AML status

Cost, time, and labor considerations still make the Sanger method a better choice amidst new sequencing technologies

New resource from the National Comprehensive Cancer Network outlines how and why to access genetic counseling and testing for multiple hereditary cancers

The test enables precise detection of a range of complex genomic alterations that are features of many rare diseases and undetectable by traditional approaches

A working knowledge of celiac disease testing options increases effectiveness of detection and diagnosis